[HTML][HTML] Relationship between amyloid-β deposition and blood–brain barrier dysfunction in Alzheimer's disease
D Wang, F Chen, Z Han, Z Yin, X Ge… - Frontiers in Cellular …, 2021 - frontiersin.org
Amyloid-β (Aβ) is the predominant pathologic protein in Alzheimer's disease (AD). The
production and deposition of Aβ are important factors affecting AD progression and …
production and deposition of Aβ are important factors affecting AD progression and …
[HTML][HTML] Aptamer-engineered (nano) materials for theranostic applications
A diverse array of organic and inorganic materials, including nanomaterials, has been
extensively employed in multifunctional biomedical applications. These applications …
extensively employed in multifunctional biomedical applications. These applications …
[HTML][HTML] Small-molecule theranostics in Alzheimer's disease
Á Sarabia-Vallejo, P López-Alvarado… - European Journal of …, 2023 - Elsevier
Alzheimer's Disease (AD) remains one of the most challenging health-related issues for our
society. It is becoming increasingly prevalent, especially in developed countries, due to the …
society. It is becoming increasingly prevalent, especially in developed countries, due to the …
[HTML][HTML] Aβ plaques
LC Walker - Free neuropathology, 2020 - ncbi.nlm.nih.gov
Aβ plaques are one of the two lesions in the brain that define the neuropathological
diagnosis of Alzheimer's disease. Plaques are highly diverse structures; many of them …
diagnosis of Alzheimer's disease. Plaques are highly diverse structures; many of them …
[HTML][HTML] Potential implications of miRNAs in the pathogenesis, diagnosis, and therapeutics of Alzheimer's disease
L Wang, X Shui, Y Diao, D Chen, Y Zhou… - International Journal of …, 2023 - mdpi.com
Alzheimer's disease (AD) is a complex multifactorial disorder that poses a substantial
burden on patients, caregivers, and society. Considering the increased aging population …
burden on patients, caregivers, and society. Considering the increased aging population …
[HTML][HTML] Metallic nanostructure-based aptasensors for robust detection of proteins
N Rabiee, S Ahmadi, K Rahimizadeh, S Chen… - Nanoscale …, 2024 - pubs.rsc.org
There is a significant need for rapid, cost-effective, and highly sensitive protein target
detection, particularly in the fields of food, environmental monitoring, and healthcare. The …
detection, particularly in the fields of food, environmental monitoring, and healthcare. The …
Nanoparticles-assisted aptamer biosensing for the detection of environmental pathogens
Given the importance of public health, it is crucial to develop quick, targeted, highly
sensitive, and accurate technologies to monitor pathogenic microbes in response to the …
sensitive, and accurate technologies to monitor pathogenic microbes in response to the …
[HTML][HTML] Mangosteen pericarp and its bioactive xanthones: Potential therapeutic value in Alzheimer's disease, Parkinson's disease, and depression with …
HTT Do, J Cho - International journal of molecular sciences, 2020 - mdpi.com
Alzheimer's disease (AD), Parkinson's disease (PD), and depression are growing burdens
for society globally, partly due to a lack of effective treatments. Mangosteen (Garcinia …
for society globally, partly due to a lack of effective treatments. Mangosteen (Garcinia …
[HTML][HTML] Contribution of A-to-I RNA editing, M6A RNA Methylation, and Alternative Splicing to physiological brain aging and neurodegenerative diseases
V Tassinari, P La Rosa, E Guida, A Colopi… - Mechanisms of ageing …, 2023 - Elsevier
Aging is a physiological and progressive phenomenon in all organisms' life cycle,
characterized by the accumulation of degenerative processes triggered by several …
characterized by the accumulation of degenerative processes triggered by several …
Precision medicine through antisense oligonucleotide-mediated exon skipping
Clinical implementation of two recently approved antisense RNA therapeutics–Exondys51®
to treat Duchenne muscular dystrophy (Duchenne MD) and Spinraza® as a treatment for …
to treat Duchenne muscular dystrophy (Duchenne MD) and Spinraza® as a treatment for …